Fluorescence bronchoscopy, one of several new initiatives in the field of early lung cancer detection, is currently being evaluated as a method for detecting dysplasia, carcinoma in situ, and early microinvasive carcinoma involving the large airways. This article will review recent developments in this area and consider the possible role of this technique in lung cancer management. General issues related to lung cancer screening are presented separately.
FLUORESCENCE BRONCHOSCOPY
Authors
Elizabeth Passalidou, MD
Jeremy George, MD